Rigrodsky & Long, P.A. Announces Investigation Of Onyx Pharmaceuticals, Inc. Buyout
28 August 2013 - 8:09AM
Business Wire
Rigrodsky & Long, P.A.:
- Do you own shares of Onyx
Pharmaceuticals, Inc. (NASDAQ GS: ONXX)?
- Did you purchase any of your shares
prior to August 25, 2013?
- Do you think the proposed buyout
price is too low?
- Do you want to discuss your
rights?
Rigrodsky & Long, P.A. announces that it is investigating
potential legal claims against the board of directors of Onyx
Pharmaceuticals, Inc. (“Onyx” or the “Company”) (NASDAQ GS: ONXX)
regarding possible breaches of fiduciary duties and other
violations of law related to the Company’s entry into an agreement
to be acquired by Amgen Inc. (“Amgen”) (NASDAQ GS: AMGN) in a
transaction valued at approximately $10.4 billion.
Click here to learn more:
http://www.rigrodskylong.com/investigations/onyx-pharmaceuticals-inc-onxx.
Under the terms of the agreement, public shareholders of Onyx
will receive $125.00 per share in cash for each share of Onyx they
own.
The investigation concerns whether Onyx’s board of directors
failed to adequately shop the Company and obtain the best possible
value for Onyx’s shareholders before entering into an agreement
with Amgen. According to Yahoo! Finance, at least one analyst has
set a price target for Onyx stock at $160.00 per share.
If you own the common stock of Onyx and purchased your shares
before August 25, 2013, if you have information or would like to
learn more about these claims, or if you wish to discuss these
matters or have any questions concerning this announcement or your
rights or interests with respect to these matters, please contact
Brian Long or Shaye Fuchs at Rigrodsky & Long, P.A., 825 East
Gate Boulevard, Suite 300, Garden City, New York 11530, by
telephone at (888) 969-4242; by e-mail to info@rl-legal.com, or at:
http://www.rigrodskylong.com/investigations/onyx-pharmaceuticals-inc-onxx.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware
and Garden City, New York, regularly prosecutes securities class,
derivative and direct actions, shareholder rights litigation and
corporate governance litigation, on behalf of shareholders in
states and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a similar
outcome.
Rigrodsky & Long, P.A.Brian LongShaye
Fuchs888-969-4242516-683-3516Fax:
302-654-7530info@rl-legal.comhttp://www.rigrodskylong.com
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024